Literature DB >> 15983292

Relationships between symptoms and venous disease: the San Diego population study.

Robert D Langer1, Elena Ho, Julie O Denenberg, Arnost Fronek, Matthew Allison, Michael H Criqui.   

Abstract

BACKGROUND: The associations between symptoms and venous disease of the lower extremities are poorly characterized.
METHODS: We conducted a cross-sectional study to evaluate relationships between symptoms associated with venous disease and prevalent disease in 2408 men and women aged 29 to 91 years who were employees, retirees, or spouses at a large state university. Index participants were randomly selected within strata by age, sex, and ethnicity. A structured interview assessed the prevalence of aching, itching, heaviness, tired legs, cramping, swelling, and nighttime restless legs. A comprehensive standardized examination determined the prevalence of visible disease (normal, telangiectasias, varicose veins, and trophic changes) and functional disease (normal, superficial, and deep disease). We related symptoms to disease with attention to modification by sex, ethnicity, and age.
RESULTS: Aching, itching, heaviness, tired legs, cramping, and swelling were related to both superficial and deep functional disease. The same symptoms were related to varicose veins and trophic changes. Swelling and heaviness were related to telangiectatic disease. Except for restless legs and trophic changes, the prevalence of symptoms across each category was greater in women than men. Aching was the most common symptom but was relatively nonspecific. Swelling was the most specific marker for prevalent visible and functional disease. Heaviness and itching also helped to distinguish prevalent disease.
CONCLUSIONS: Venous symptoms were more prevalent in study participants with both visible and functional disease and in women. Swelling was the most specific predictor; heaviness, itching, and aching also helped to distinguish cases.

Entities:  

Mesh:

Year:  2005        PMID: 15983292     DOI: 10.1001/archinte.165.12.1420

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  Acute venous occlusion enhances matrix metalloprotease activity: Implications on endothelial dysfunction.

Authors:  Tom Alsaigh; Elizabeth S Pocock; John J Bergan; Geert W Schmid-Schönbein
Journal:  Microvasc Res       Date:  2010-10-16       Impact factor: 3.514

2.  Adipokines are associated with lower extremity venous disease: the San Diego population study.

Authors:  M A Allison; M Cushman; P W Callas; J O Denenberg; N E Jensky; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

3.  Higher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population Study.

Authors:  Locke J Bryan; Peter W Callas; Michael H Criqui; Mary Cushman
Journal:  Thromb Res       Date:  2012-08-12       Impact factor: 3.944

4.  Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study.

Authors:  M Cushman; P W Callas; J O Denenberg; E G Bovill; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-05-21       Impact factor: 5.824

Review 5.  Infection in Venous Leg Ulcers: Considerations for Optimal Management in the Elderly.

Authors:  Douglas J Pugliese
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

6.  A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.

Authors:  Kathleen Gibson; Lowell Kabnick
Journal:  Phlebology       Date:  2016-07-09       Impact factor: 1.740

7.  Hyperelastic Properties of Platinum Cured Silicones and its Applications in Active Compression.

Authors:  Gayani K Nandasiri; Anton Ianakiev; Tilak Dias
Journal:  Polymers (Basel)       Date:  2020-01-07       Impact factor: 4.329

8.  A realist evaluation to identify targets to improve the organization of compression therapy for deep venous thrombosis- and chronic venous disease patients.

Authors:  Rachel H P Schreurs; Manuela A Joore; Daisy P De Bruijn-Geraets; Hugo Ten Cate; Arina J Ten Cate-Hoek
Journal:  PLoS One       Date:  2022-08-08       Impact factor: 3.752

9.  A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities.

Authors:  Michael Vasquez; Antonios P Gasparis
Journal:  Phlebology       Date:  2016-03-07       Impact factor: 1.740

10.  Prevention and treatment of the post-thrombotic syndrome.

Authors:  Arina J Ten Cate-Hoek
Journal:  Res Pract Thromb Haemost       Date:  2018-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.